• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:MBIO)

0.2500 UNCHANGED
Streaming Delayed Price Updated: 1:49 PM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MBIO

< Previous 1 2 3 Next >
News headline image
MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
October 28, 2023
Via ACCESSWIRE
News headline image
Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
October 26, 2023
Via ACCESSWIRE
News headline image
MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001
October 24, 2023
Via ACCESSWIRE
News headline image
Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
October 05, 2023
Via ACCESSWIRE
News headline image
Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research
September 14, 2023
Via ACCESSWIRE
News headline image
MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
September 05, 2023
Via ACCESSWIRE
News headline image
Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
August 24, 2023
Via ACCESSWIRE
News headline image
Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials
August 18, 2023
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap